Key Points - Multiple law firms have filed class action lawsuits against Hyliion Holdings Corp. (HYLN) for securities fraud between May 12, 2026, and June 23, 2026. - Investors who suffered losses are urged to contact the respective law firms before the October 27, 2026 deadline. - Allegations include Hyliion overstating a data center partnership,...
Key Points - Rosen Law Firm reminds Flotek Industries investors of the October 26, 2026 lead...
Key Points - Rosen Law Firm reminds investors of Capricor Therapeutics securities class action lawsuit deadline...
A 2.0% up gap appeared on Vaxart, Inc. (VXRT)'s chart — and the first question every...
Every position is an argument with someone on the other side. Here is what the numbers...
from Industrial Alliance Securities issued a price target of $27.00 for MDWD on 2026-09-16 13:05:28.The adjusted price target was set to $27.00.At the time of the announcement, MDWD was trading...
Luca Issi from RBC Capital issued a price target of $18.00 for SLDB on 2026-09-16 10:05:50.The adjusted price target was set to $18.00.At the time of the announcement, SLDB was...
from Chardan Capital issued a price target of $18.75 for MOVE on 2026-09-16 08:52:31.The adjusted price target was set to $18.75.At the time of the announcement, MOVE was trading at...
Lukas Shumway from Barclays issued a price target of $1.30 for CLLS on 2026-09-16 07:49:00.The adjusted price target was set to $1.30.At the time of the announcement, CLLS was trading...
from Lake Street issued a price target of $44.00 for FTK on 2026-09-15 12:47:10.The adjusted price target was set to $44.00.At the time of the announcement, FTK was trading at...
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
